Brief: Nuvation Bio Q4 EPS USD -0.06
29/02/2024 21:01
Feb 29 (Reuters) - Nuvation Bio Q4 operating expenses USD 20.831 million. * Q4 pretax profit USD -13.787 million * Q4 net income USD -13.787 million * Q4 operating profit USD -20.831 million
Recent news on Nuvation Bio
See all newsBrief: Nuvation Bio To Expand Pivotal Phase 3 Sigma Study Of Safusidenib For Idh1-Mutant Glioma To Six European Countries
Brief: Nuvation Bio To Report Third Quarter 2026 Financial Results And Provide Business Update On November 4, 2026
U.S. RESEARCH ROUNDUP-Everpure, Marvell Technology, Okta
Nuvation Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Nuvation Bio Q2 revenue beats estimates on IBTROZI growth